1,388 research outputs found

    Commonwealth of Pennsylvania\u27s GED graduates progress.

    Get PDF
    A follow-up study of 3,099 GED graduates in Pennsylvania from 1974 through 1994 was conducted to identify changes in employment characteristics, living arrangements, and income, as well as preparation for the GED, further education, and outcomes of passing the GED. All findings indicated that GED graduates perceived obtaining the GED as extremely beneficial

    America Can Win: The Case for Military Reform

    Get PDF

    The Polarized Spectrum of Apm 08279+5255

    Get PDF
    We report the discovery of significant linear polarization (p > 1%) in the hyperluminous z=3.87 BALQSO APM~08279+5255. The polarization spectrum is complex, with properties similar to those of other, lower redshift but more highly polarized BALQSOs. The resonance emission lines are unpolarized while the absorption troughs show polarization similar to or higher than the continuum. In particular, an apparent increase of polarization in the trough covering 1000-1030 angstroms (rest) supports the interpretation of this feature as a broad absorption component associated with OVI/Ly_beta local to the QSO, as opposed to an intervening damped Ly_alpha absorption system. The elevated polarization in some of the absorption features implies that we view the scattered (polarized) spectrum through a sightline with less absorbing material than the direct spectrum. Therefore, the complex structure of the polarization spectrum in this brilliant lensed BALQSO suggests that it will be an important laboratory for studying the structure of QSOs at high redshift.Comment: 8 pages, 1 figure. Accepted for publication in The Astrophysical Journal Letter

    Predicting response to anti-TNFĪ± therapy among patients with axial spondyloarthritis (axSpA) : results from BSRBR-AS

    Get PDF
    We are grateful to the staff of the British Society for Rheumatology Biologics Register in Axial Spondyloarthritis register and to the recruiting staff at the clinical centres, details of which are available at: https://www.abdn.ac.uk/iahs/research/epidemiology/spondyloarthritis.php#panel1011. We are grateful to Jonathan Lock for commenting on the manuscript. Funding: This work was supported by the British Society for Rheumatology (BSR) who have funded the BSRBR-AS. The BSR received funding for this from Pfizer, AbbVie and UCB. These companies receive advance copies of manuscripts for comments but have no input in to the topics for analysis in the register nor the work involved in undertaking analysis. Analysis of data was supported by the Versus Arthritis/Medical Research Council Centre for Musculoskeletal Health and Work [grant number 20665].Peer reviewe

    Real-world evidence of TNF inhibition in axial spondyloarthritis : can we generalise the results from clinical trials?

    Get PDF
    Funding This work was supported by the British Society for Rheumatology (BSR) who funded the BSRBR-AS. The BSR received funding for this from Pfizer, AbbVie and UCB. These companies receive advance copies of manuscripts for comments but have no input in to the topics for analysis in the register nor the work involved in undertaking analysis. Analysis of data was supported by the Versus Arthritis/Medical Research Council Centre for Musculoskeletal Health and Work (grant number 20665).Peer reviewedPostprin

    The risk of inflammatory bowel disease in patients with axial spondyloarthritis treated with biologic agents : BSRBR-AS and meta-analysis

    Get PDF
    Funding: The BSRBR-AS is supported by the British Society for Rheumatology and they have received funds for the registry from Pfizer, AbbVie and UCB. These companies have no input in determining the topics for analysis or work involved in undertaking it but do receive an advance copy of the manuscript on which they may make comments. ACKNOWLEDGEMENTS: The original idea for the study was suggested by John Mansfield and discussed with Lesley Kay (both Newcastle upon Tyne Hospitals NHS Foundation Trust). All authors discussed and contributed to designing this study and the analysis plan, which was undertaken by RLB and (updated and) overseen by OR, LED and GJM. Results were reviewed by all authors. GJM, RLB, OR and LED all contributed to drafting the manuscript which was critically reviewed by all authors. RLB undertook this work while a visiting student based at the University of Aberdeen from Ludwig-Maximilians UniversitƤt (Munich).Peer reviewedPostprin

    Faculty Email Exchanges

    Get PDF
    Email exchanges between University of Denver and Northwestern University on studies of John Evans and the Sand Creek Massacre

    Outcomes and treatment responses, including work productivity, among people with axial spondyloarthritis living in urban and rural areas : a mixed-methods study within a national register

    Get PDF
    ACKNOWLEDGEMENTS We are grateful to the staff of the British Society for Rheumatology Biologics Register in Axial Spondyloarthritis register who at the time of the study were Elizabeth Ferguson-Jones, Maureen Heddle, Nafeesa Nazlee and Barry Morris, and to the recruiting staff at the clinical centres, details of which are available at: https://www.abdn.ac.uk/iahs/research/epidemiology/spondyloarthritis.php#panel1011. FUNDING The BSRBR-AS is funded by the British Society of Rheumatology who have received funding for this, in part, from Pfizer, Abbvie and UCB. These companies receive advance copies of results but have no input in determining the topics for analysis or work involved in undertaking it. This work was conducted within the Versus Arthritis/Medical Research Council Centre for Musculoskeletal Work and Health (Grant No: 20665).Peer reviewedPublisher PD

    Scotland Registry for Ankylosing Spondylitis (SIRAS) ā€“ Protocol

    Get PDF
    Funding SIRAS was funded by unrestricted grants from Pfizer and AbbVie. The project was reviewed by both companies, during the award process, for Scientific merit, to ensure that the design did not compromise patient safety, and to assess the global regulatory implications and any impact on regulatory strategy.Publisher PD
    • ā€¦
    corecore